IDEC PHARMACEUTICALS CORP / DE 4

Accession 0001236538-03-000004

$BIIBCIK 0000875045operating

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 6:22 PM ET

Size

37.1 KB

Accession

0001236538-03-000004

Insider Transaction Report

Form 4

Period: 2003-09-02

IDEC PHARMACEUTICALS CORP / DEIDPH

RODRIGUEZ EDWARD

VP and Controller

Transactions

Exercise/Conversion
Incentive Stock Option (right to buy)
2003-08-29−9,105→ 8,895 total
Exercise: $16.26From: 2000-09-16Exp: 2009-09-23→ Common Stock (9,105 underlying)
Exercise/Conversion
Common Stock
2003-08-29$7.42/sh+680$5,043→ 5,964 total
Sale
Common Stock
2003-08-29$34.68/sh−9,105$315,764→ 5,284 total
Other
Common Stock
2003-06-30$28.87/sh+18$520→ 5,284 total
Exercise/Conversion
Common Stock
2003-08-29$5.25/sh+2,100$11,025→ 7,384 total
Sale
Common Stock
2003-09-02$33.84/sh−9,895$334,798→ 7,100 total(indirect: By Trust)
Other
Common Stock
2003-03-31$29.09/sh+40$1,163→ 5,266 total
Sale
Common Stock
2003-08-29$34.68/sh−1,490$51,674→ 5,284 total
Sale
Common Stock
2003-08-29$34.68/sh−680$23,583→ 5,284 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2003-08-29−680→ 24,920 total
Exercise: $7.42From: 1998-12-16Exp: 2008-02-19→ Common Stock (680 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2003-08-29−2,100→ 2,940 total
Exercise: $5.25From: 1999-04-01Exp: 2008-05-20→ Common Stock (2,100 underlying)
Sale
Common Stock
2003-08-29$34.68/sh−2,100$72,829→ 5,284 total
Exercise/Conversion
Common Stock
2003-08-29$9.51/sh+4,250$40,419→ 9,534 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2003-08-29−4,250→ 10,750 total
Exercise: $9.51From: 2000-04-01Exp: 2009-04-20→ Common Stock (4,250 underlying)
Exercise/Conversion
Common Stock
2003-08-29$16.26/sh+9,105$148,051→ 14,389 total
Sale
Common Stock
2003-08-29$34.68/sh−4,250$147,391→ 5,284 total
Exercise/Conversion
Common Stock
2003-08-29$4.35/sh+1,490$6,488→ 6,774 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2003-08-29−1,490→ 8,510 total
Exercise: $4.35From: 1997-04-16Exp: 2006-04-23→ Common Stock (1,490 underlying)

Footnotes (7)

[F1]Acquisition of shares under the Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c).
[F2]Granted under Issuer's Employee Stock Option Plan, in an exempt transaction under SEC rule 16b-3(d).
[F3]Option was originally granted for 12,000 shares and became exercisable as follows: 25% of the optioned shares on 4/16/97 and as to the balance of the shares in 36 equal monthly installments thereafter.
[F4]Option was originally granted for 5,040 shares and became exercisable as follows: 25% of the optioned shares on 4/1/99 and as to the balance of the shares in 36 equal monthly installments thereafter.
[F5]Option was originally granted for 33,600 shares and became exercisable as follows: 25% of the optioned shares on 12/16/98 and as to the balance of the shares in 36 equal monthly installments thereafter.
[F6]Option was originally granted for 15,000 shares and became exercisable as follows: 25% of the optioned shares on 4/1/00 and as to the balance of the shares in 36 equal monthly installments thereafter.
[F7]Option was originally granted for 18,000 shares and became exercisable as follows: 25% of the optioned shares on 9/16/00 and as to the balance of the shares in 36 equal monthly installments thereafter.

Documents

2 files

Issuer

IDEC PHARMACEUTICALS CORP / DE

CIK 0000875045

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000875045

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 6:22 PM ET
Size: 37.1 KB

View on SEC.gov